BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matsumoto Y, Amano I, Hirose S, Tsuruta Y, Hara S, Murata M, Imai T. Effects of L-carnitine supplementation on renal anemia in poor responders to erythropoietin. Blood Purif. 2001;19:24-32. [PMID: 11114574 DOI: 10.1159/000014474] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Litos C, Parsons S, Karaliota A. Synthesis of two dicopper(II) complexes of l-carnitine: The first structural determination of a metal complex containing l-carnitine. Polyhedron 2007;26:1397-403. [DOI: 10.1016/j.poly.2006.11.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
2 Fischer JR, Pantaleo V, Francey T, Cowgill LD. Veterinary hemodialysis: advances in management and technology. Veterinary Clinics of North America: Small Animal Practice 2004;34:935-67. [DOI: 10.1016/j.cvsm.2004.03.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
3 Maruyama T, Higuchi T, Yamazaki T, Okawa E, Ando H, Oikawa O, Inoshita A, Okada K, Abe M. Levocarnitine Injections Decrease the Need for Erythropoiesis-Stimulating Agents in Hemodialysis Patients with Renal Anemia. Cardiorenal Med 2017;7:188-97. [PMID: 28736559 DOI: 10.1159/000462983] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
4 Suzuki A, Sakai Y, Hashimoto K, Osawa H, Tsuruoka S. Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients. Ren Fail 2018;40:196-200. [PMID: 29616582 DOI: 10.1080/0886022X.2018.1455587] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
5 Malaguarnera M, Vacante M, Giordano M, Motta M, Bertino G, Pennisi M, Neri S, Malaguarnera M, Volti GL, Galvano F. L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin. World J Gastroenterol 2011; 17(39): 4414-4420 [PMID: 22110268 DOI: 10.3748/wjg.v17.i39.4414] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
6 Golper TA, Goral S, Becker BN, Langman CB. l-carnitine treatment of anemia. American Journal of Kidney Diseases 2003;41:S27-34. [DOI: 10.1016/s0272-6386(03)00114-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
7 Matsumoto Y, Furuta A, Furuta S, Miyajima M, Sugino T, Nagata K, Sawada S. The Impact of Pre-Dialytic Endurance Training on Nutritional Status and Quality of Life in Stable Hemodialysis Patients (Sawada Study). Renal Failure 2009;29:587-93. [DOI: 10.1080/08860220701392157] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
8 Sun Y, Liu G, Li X, Shi Y, Guan G. L -Carnitine inhibits eryptosis induced by uremic serum and the related mechanisms. Renal Failure 2015;37:1050-6. [DOI: 10.3109/0886022x.2015.1052977] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
9 Weinhandl ED, Rao M, Gilbertson DT, Collins AJ, Pereira BJ. Protective effect of intravenous levocarnitine on subsequent-month hospitalization among prevalent hemodialysis patients, 1998 to 2003. Am J Kidney Dis. 2007;50:803-812. [PMID: 17954293 DOI: 10.1053/j.ajkd.2007.07.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
10 Berns JS, Mosenkis A. Pharmacologic adjuvants to epoetin in the treatment of anemia in patients on hemodialysis. Hemodialysis International 2005;9:7-22. [DOI: 10.1111/j.1492-7535.2005.01113.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
11 Reuter SE, Faull RJ, Ranieri E, Evans AM. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients. Nephrol Dial Transplant. 2009;24:990-996. [PMID: 18987259 DOI: 10.1093/ndt/gfn588] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
12 Schreiber B. Levocarnitine and Dialysis: A Review. Nutr Clin Pract 2017;20:218-43. [DOI: 10.1177/0115426505020002218] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
13 Daimon S, Yasuda M, Nishitani M. Serum carnitine concentration and the acyl to free carnitine ratio in nondialysis chronic kidney disease and hemodialysis patients. Ther Apher Dial 2022;26:122-9. [PMID: 33656789 DOI: 10.1111/1744-9987.13638] [Reference Citation Analysis]
14 Takashima H, Maruyama T, Abe M. Significance of Levocarnitine Treatment in Dialysis Patients. Nutrients 2021;13:1219. [PMID: 33917145 DOI: 10.3390/nu13041219] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Hoppel C. The role of carnitine in normal and altered fatty acid metabolism. Am J Kidney Dis. 2003;41:S4-12. [PMID: 12751049 DOI: 10.1016/s0272-6386(03)00112-4] [Cited by in Crossref: 140] [Cited by in F6Publishing: 72] [Article Influence: 7.8] [Reference Citation Analysis]
16 Dębska-ślizień A, Owczarzak A, Kunicka D, Łysiak-szydłowska W, Rutkowski B. Plasma Carnitine Profile during Chronic Renal Anemia Treatment with Recombinant Human Erythropoietin. Int J Artif Organs 2003;26:33-8. [DOI: 10.1177/039139880302600106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Chamney M, Pugh-Clarke K, Kafkia T, Wittwer I. CE: Continuing Education Article: MANAGEMENT OF ANAEMIA IN CHRONIC KIDNEY DISEASE. J Ren Care 2010;36:102-11. [PMID: 20591006 DOI: 10.1111/j.1755-6686.2010.00149.x] [Reference Citation Analysis]
18 Bellinghieri G, Santoro D, Calvani M, Mallamace A, Savica V. Carnitine and hemodialysis. Am J Kidney Dis 2003;41:S116-22. [PMID: 12612967 DOI: 10.1053/ajkd.2003.50099] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
19 Kadiroglu AK, Yilmaz ME, Sit D, Kara IH, Isikoglu B. The Evaluation of Postdialysis l -Carnitine Administration and Its Effect on Weekly Requiring Doses of rHuEPO in Hemodialysis Patients. Renal Failure 2009;27:367-72. [DOI: 10.1081/jdi-65296] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
20 Sato S, Moriya K, Furukawa M, Saikawa S, Namisaki T, Kitade M, Kawaratani H, Kaji K, Takaya H, Shimozato N, Sawada Y, Seki K, Kitagawa K, Akahane T, Mitoro A, Okura Y, Yamao J, Yoshiji H. Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection. Clin Mol Hepatol 2019;25:65-73. [PMID: 30798587 DOI: 10.3350/cmh.2018.0070] [Reference Citation Analysis]
21 Deng X, Jiang N, Guo L, Wang C, Li J, Liu X, Zhu B, Cai R, Chen Y, Wang T, Liu L. Protective Effects and Metabolic Regulatory Mechanisms of Shenyan Fangshuai Recipe on Chronic Kidney Disease in Rats. Evid Based Complement Alternat Med 2020;2020:5603243. [PMID: 32908562 DOI: 10.1155/2020/5603243] [Reference Citation Analysis]
22 Karlic H, Lohninger A. Supplementation of L-carnitine in athletes: does it make sense? Nutrition. 2004;20:709-715. [PMID: 15212755 DOI: 10.1016/j.nut.2004.04.003] [Cited by in Crossref: 85] [Cited by in F6Publishing: 54] [Article Influence: 5.0] [Reference Citation Analysis]
23 Reuter SE, Faull RJ, Evans AM. L-carnitine supplementation in the dialysis population: are Australian patients missing out? Nephrology (Carlton) 2008;13:3-16. [PMID: 18199095 DOI: 10.1111/j.1440-1797.2007.00817.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
24 Matera M, Bellinghieri G, Costantino G, Santoro D, Calvani M, Savica V. History of L-carnitine: Implications for renal disease. Journal of Renal Nutrition 2003;13:2-14. [DOI: 10.1053/jren.2003.50010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.0] [Reference Citation Analysis]